Patent · US Active

Formulations of AG10

US12005043B2 · kind B2 · utility

0Cited by
64References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 18, 2022
Grant dateJun 11, 2024
Priority date
Expiry dateJan 18, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/2833
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides high-load tablet formulations of AG10 or a pharmaceutically acceptable salt thereof. In some aspects, provided herein are table formulations of AG10 or a pharmaceutically acceptable salt thereof that include at least 40% or more AG10 by weight and at least one pharmaceutical excipient selected from one or more fillers, one or more binders, one or more disintegrants, and one or more lubricants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.